Completes – Vitavo Yage

Sleep Disorders Healthcare

Clinical Trial Update: New Oral Sleep Apnea Drug Completes Phase 2 Dosing

Incannex Healthcare (NASDAQ: IXHL) has completed patient dosing…

Continue Reading